Evan Kearns Cogent Biosciences, Inc. (COGT) insider trading activity

COGT Quotes by TradingView

Evan Kearns is Chief Legal Officer of Cogent Biosciences, Inc.. Currently has a direct ownership of 109,398 shares of COGT, which is worth approximately $3.67 Million. The most recent transaction as insider was on Dec 26, 2025, when has been sold 65,000 shares (Common Stock) at a price of $38.7 per share, resulting in proceeds of $2,515,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 109K
n/a 3M change
n/a 12M change
Total Value Held $3.67 Million

Evan Kearns Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 26 2025
SELL
Open market or private sale
$2,515,500 $38.7 p/Share
65,000 Reduced 37.27%
109,398 Common Stock
Dec 17 2025
SELL
Payment of exercise price or tax liability
$4,954,998 $39.45 p/Share
125,602 Reduced 41.87%
174,398 Common Stock
Dec 17 2025
BUY
Grant, award, or other acquisition
-
300,000 Added 50.0%
300,000 Common Stock

Also insider at

AGEN
AGENUS INC Healthcare
VP and General Counsel
EK

Evan Kearns

Chief Legal Officer
Lexington, MA

Track Institutional and Insider Activities on COGT

Follow Cogent Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COGT shares.

Notify only if

Insider Trading

Get notified when an Cogent Biosciences, Inc. insider buys or sells COGT shares.

Notify only if

News

Receive news related to Cogent Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on COGT